Medtronic: Riding On Next-Gen Tech Medical Devices (NYSE:MDT)
· seekingalpha.com
Medtronic Buy rating: cardiovascular device leadership, FY2026 revenue +8.4%, and FY2027 7% growth guide. Click for more on MDT stock.
Technology in health is one of my areas of interest, and I believe nothing beats a healthy human being. In fact, technology is reshaping longevity at the indivi...